• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪酸合酶(FAS)和表皮生长因子受体2(ErbB2)在非恶性和恶性口腔角质形成细胞中的差异表达。

Differential expression of fatty acid synthase (FAS) and ErbB2 in nonmalignant and malignant oral keratinocytes.

作者信息

Silva Sabrina D, Cunha Isabela W, Rangel Ana Lúcia C A, Jorge Jacks, Zecchin Karina G, Agostini Michelle, Kowalski Luiz P, Coletta Ricardo D, Graner Edgard

机构信息

Departament of Oral Diagnosis, School of Dentistry of Piracicaba, State University of Campinas, Av. Limeira 901, CP 52, Areão, Piracicaba, CEP SP, Brazil.

出版信息

Virchows Arch. 2008 Jul;453(1):57-67. doi: 10.1007/s00428-008-0626-5. Epub 2008 Jun 6.

DOI:10.1007/s00428-008-0626-5
PMID:18528705
Abstract

The aim of this study was to investigate fatty acid synthase (FAS) and ErbB2 expression in nonmalignant oral epithelium and oral or head and neck squamous cell carcinomas (OSCC/HNSCC). Morphologically normal, hyperkeratotic, and dysplastic oral epithelium as well as well-differentiated and poorly differentiated OSCC were immunohistochemically evaluated for FAS, ErbB2, and Ki-67. These proteins were also analyzed in a tissue microarray with 55 HNSCC. SCC-9 cells were used to study FAS and ErbB2 during differentiation. FAS expression was higher in hyperkeratosis, dysplasias, and OSCC than in normal epithelium. Well-differentiated OSCC/HNSCC were more positive for FAS than the poorly differentiated tumors. ErbB2 was observed at the surface of nonmalignant and well-differentiated OSCC/HNSCC keratinocytes and in the cytoplasm of poorly differentiated cells. Ki-67 index was progressively higher from normal oral epithelium to OSCC, inversely correlated with cell surface ErbB2, and positively correlated with intracytoplasmic ErbB2. Finally, SCC-9 cell cultures were enriched in membrane ErbB2-positive cells after differentiation by anchorage deprivation. In conclusion, FAS is overexpressed in OSCC/HNSCC and hyperkeratotic oral epithelium and ErbB2 is found at the cell surface of differentiating keratinocytes and in the cytoplasm of poorly differentiated tumor cells. Ki-67 index is higher in epithelial dysplasias and OSCC than in morphologically normal oral epithelium.

摘要

本研究旨在调查非恶性口腔上皮以及口腔或头颈部鳞状细胞癌(OSCC/HNSCC)中脂肪酸合酶(FAS)和表皮生长因子受体2(ErbB2)的表达情况。采用免疫组织化学方法评估形态学正常、角化过度、发育异常的口腔上皮以及高分化和低分化OSCC中的FAS、ErbB2和Ki-67。还在含有55例HNSCC的组织芯片中分析了这些蛋白。利用SCC-9细胞研究分化过程中的FAS和ErbB2。FAS在角化过度、发育异常和OSCC中的表达高于正常上皮。高分化OSCC/HNSCC中FAS阳性率高于低分化肿瘤。在非恶性和高分化OSCC/HNSCC角质形成细胞表面以及低分化细胞的细胞质中观察到ErbB2。Ki-67指数从正常口腔上皮到OSCC逐渐升高,与细胞表面ErbB2呈负相关,与细胞质内ErbB2呈正相关。最后,通过锚定剥夺法诱导SCC-9细胞分化后,细胞膜上ErbB2阳性细胞增多。总之,FAS在OSCC/HNSCC和角化过度的口腔上皮中过表达,ErbB2在分化的角质形成细胞表面和低分化肿瘤细胞的细胞质中表达。上皮发育异常和OSCC中的Ki-67指数高于形态学正常的口腔上皮。

相似文献

1
Differential expression of fatty acid synthase (FAS) and ErbB2 in nonmalignant and malignant oral keratinocytes.脂肪酸合酶(FAS)和表皮生长因子受体2(ErbB2)在非恶性和恶性口腔角质形成细胞中的差异表达。
Virchows Arch. 2008 Jul;453(1):57-67. doi: 10.1007/s00428-008-0626-5. Epub 2008 Jun 6.
2
Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas.泛素特异性蛋白酶 2a(USP2a)、脂肪酸合酶(FASN)和 ErbB2 表达在口腔鳞状细胞癌中的临床病理意义。
Oral Oncol. 2009 Oct;45(10):e134-9. doi: 10.1016/j.oraloncology.2009.02.004. Epub 2009 Apr 9.
3
Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study.脂肪酸合酶、表皮生长因子受体2(ErbB2)和Ki-67在头颈部鳞状细胞癌中的表达:一项临床病理研究
Oral Oncol. 2004 Aug;40(7):688-96. doi: 10.1016/j.oraloncology.2004.01.004.
4
ErbB2 and fatty acid synthase (FAS) expression in 102 squamous cell carcinomas of the tongue: correlation with clinical outcomes.102例舌鳞状细胞癌中ErbB2和脂肪酸合酶(FAS)的表达:与临床结果的相关性
Oral Oncol. 2008 May;44(5):484-90. doi: 10.1016/j.oraloncology.2007.06.008. Epub 2007 Sep 6.
5
Effects of FasL expression in oral squamous cell cancer.FasL表达在口腔鳞状细胞癌中的作用。
Asian Pac J Cancer Prev. 2013;14(1):281-5. doi: 10.7314/apjcp.2013.14.1.281.
6
Caspase-3 expression is reduced, in the absence of cleavage, in terminally differentiated normal oral epithelium but is increased in oral squamous cell carcinomas and correlates with tumour stage.在终末分化的正常口腔上皮中,半胱天冬酶-3的表达在未发生裂解的情况下降低,但在口腔鳞状细胞癌中升高,且与肿瘤分期相关。
J Pathol. 2004 Oct;204(2):175-82. doi: 10.1002/path.1630.
7
Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium.正常和恶性口腔上皮中N-钙黏蛋白表达及运动性的差异生长因子调控
J Cell Sci. 2008 Jul 1;121(Pt 13):2197-207. doi: 10.1242/jcs.021782. Epub 2008 Jun 10.
8
Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.甲状旁腺激素相关蛋白作为口腔鳞状细胞癌的预后指标。
J Exp Clin Cancer Res. 2014 Dec 18;33(1):100. doi: 10.1186/s13046-014-0100-y.
9
Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌中可靶向的ERBB2异常的鉴定
JAMA Otolaryngol Head Neck Surg. 2016 Jun 1;142(6):559-67. doi: 10.1001/jamaoto.2016.0335.
10
Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.Ki-67在不同组织学分级的口腔上皮发育异常和口腔鳞状细胞癌中的预后价值。
Asian Pac J Cancer Prev. 2018 Nov 29;19(11):3279-3286. doi: 10.31557/APJCP.2018.19.11.3279.

引用本文的文献

1
Lipid metabolism reprogramming in head and neck cancer.头颈癌中的脂质代谢重编程
Front Oncol. 2023 Oct 20;13:1271505. doi: 10.3389/fonc.2023.1271505. eCollection 2023.
2
Identification of Metabolism-Associated Biomarkers for Early and Precise Diagnosis of Oral Squamous Cell Carcinoma.鉴定口腔鳞状细胞癌早期和精准诊断相关的代谢生物标志物。
Biomolecules. 2022 Mar 4;12(3):400. doi: 10.3390/biom12030400.
3
Two different protein expression profiles of oral squamous cell carcinoma analyzed by immunoprecipitation high-performance liquid chromatography.

本文引用的文献

1
Gastrointestinal stromal tumours overexpress fatty acid synthase.胃肠道间质瘤过度表达脂肪酸合酶。
J Pathol. 2006 Jul;209(3):369-75. doi: 10.1002/path.1983.
2
A pilot study of fatty acid metabolism in oral squamous cell carcinoma.口腔鳞状细胞癌中脂肪酸代谢的一项初步研究。
Int J Oral Maxillofac Surg. 2005 Jan;34(1):78-81. doi: 10.1016/j.ijom.2004.03.001.
3
Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
采用免疫沉淀高效液相色谱法分析口腔鳞状细胞癌的两种不同蛋白质表达谱。
World J Surg Oncol. 2017 Aug 8;15(1):151. doi: 10.1186/s12957-017-1213-5.
4
A concordant expression pattern of fatty acid synthase and membranous human epidermal growth factor receptor 2 exists in gastric cancer and is associated with a poor prognosis in gastric adenocarcinoma patients.脂肪酸合酶与膜性人表皮生长因子受体2在胃癌中存在一致的表达模式,且与胃腺癌患者的不良预后相关。
Oncol Lett. 2015 Oct;10(4):2107-2117. doi: 10.3892/ol.2015.3609. Epub 2015 Aug 14.
5
Fatty acid synthase inhibitors induce apoptosis in non-tumorigenic melan-a cells associated with inhibition of mitochondrial respiration.脂肪酸合酶抑制剂可诱导非致瘤性黑素-a细胞发生凋亡,这与线粒体呼吸的抑制相关。
PLoS One. 2014 Jun 25;9(6):e101060. doi: 10.1371/journal.pone.0101060. eCollection 2014.
6
Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread.ERBB1 和 ERBB4 受体的过表达预示着伴有结外扩散的 pN+口腔鳞状细胞癌的临床预后不良。
Clin Exp Metastasis. 2014 Mar;31(3):307-16. doi: 10.1007/s10585-013-9629-y. Epub 2013 Dec 15.
7
Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia?免疫组织化学能否作为口腔上皮发育异常主观组织病理学诊断的替代方法?
Biomark Cancer. 2013 Oct 10;5:49-60. doi: 10.4137/BIC.S12951.
8
Loss of fatty acid synthase inhibits the "HER2-PI3K/Akt axis" activity and malignant phenotype of Caco-2 cells.脂肪酸合酶缺失抑制 Caco-2 细胞的“HER2-PI3K/Akt 轴”活性和恶性表型。
Lipids Health Dis. 2013 Jun 1;12:83. doi: 10.1186/1476-511X-12-83.
9
Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers.脂肪酸合酶在胰腺癌吉西他滨耐药及放射抵抗中的作用
Int J Biochem Mol Biol. 2011 Jan 1;2(1):89-98.
10
Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker.脂肪酸合酶的生物化学、分子生物学及药理学:一个新兴的治疗靶点与诊断/预后标志物
Int J Biochem Mol Biol. 2010 Jul 18;1(1):69-89.
脂肪酸合酶(FAS)的药理学抑制:一种通过抑制Her-2/neu(erbB-2)癌基因诱导的恶性转化来进行乳腺癌化学预防的新治疗方法。
Mol Carcinog. 2004 Nov;41(3):164-78. doi: 10.1002/mc.20054.
4
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells.抑制脂肪酸合酶(FAS)可抑制癌细胞中HER2/neu(erbB-2)癌基因的过表达。
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10715-20. doi: 10.1073/pnas.0403390101. Epub 2004 Jul 2.
5
Fatty acid synthase is required for the proliferation of human oral squamous carcinoma cells.脂肪酸合酶是人类口腔鳞状癌细胞增殖所必需的。
Oral Oncol. 2004 Aug;40(7):728-35. doi: 10.1016/j.oraloncology.2004.01.011.
6
Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study.脂肪酸合酶、表皮生长因子受体2(ErbB2)和Ki-67在头颈部鳞状细胞癌中的表达:一项临床病理研究
Oral Oncol. 2004 Aug;40(7):688-96. doi: 10.1016/j.oraloncology.2004.01.004.
7
The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer.异肽酶USP2a调节前列腺癌中脂肪酸合酶的稳定性。
Cancer Cell. 2004 Mar;5(3):253-61. doi: 10.1016/s1535-6108(04)00055-8.
8
Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity.奥利司他是一种具有抗肿瘤活性的新型脂肪酸合酶抑制剂。
Cancer Res. 2004 Mar 15;64(6):2070-5. doi: 10.1158/0008-5472.can-03-3645.
9
Fatty acid synthase: a metabolic oncogene in prostate cancer?脂肪酸合酶:前列腺癌中的一种代谢癌基因?
J Cell Biochem. 2004 Jan 1;91(1):47-53. doi: 10.1002/jcb.10708.
10
Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.脂肪酸合酶表达在前列腺癌中定义了不同的分子特征。
Mol Cancer Res. 2003 Aug;1(10):707-15.